DrugMonitor™ Rabbit Anti-Vicriviroc Antibody (VS-0125-YC2030) (CAT#: VS-0125-YC2030)

Vicriviroc, a CCR5 inhibitor, is being tested in clinical trials for its impact on HIV-1 management. This product is the DrugMonitor™ Anti-Vicriviroc Antibody (VS-0125-YC2030), specifically designed as an anti-drug antibody (ADA) that targets Vicriviroc. The ADA was raised in rabbits immunized with Vicriviroc conjugated to BSA and is suitable for use in ELISA and lateral flow assays. This antibody may be employed in pharmacokinetics (PK) and pharmacodynamics (PD) analyses, or as a reference standard in ADA assays. Furthermore, as a drug-based antibody, it serves as an exemplary tool for therapeutic drug monitoring, facilitating the determination of Vicriviroc drug concentrations in various samples.